Intimation of Earnings Call for the quarter and half year ended September 30, 2026

APTUS PHARMA LIMITED Date: 21st October 2026 The BSE Ltd Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400001 SECURITY CODE: 544529 SCRIPT SYMBOL: APPL Subject: Intimation of Earnings Call for the quarter and half year ended September 30, 2026 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that an Audio Earnings Call will be held on Monday, October 26, 2026, at 5:00 PM IST. During the Conference Call, the Management of the Company will discuss the financial performance of the Company for the half-year ended 30 September 2026, recent business developments, future business plans, growth strategies and business outlook. The invite giving requisite details including the registration link and dial-in details is attached herewith. The aforesaid information shall also be made available on the Company's website at www.aptus- pharma.com. Kindly take the above information on record. Thanking you, Yours faithfully, For Aptus Pharma Limited Tejash Hathi Managing Director DIN: 03151221 Regd. Address: Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logistic Park, Aslali, Daskroi, Ahmedabad, Gujarat – 382427, India Contact: 76004 27827, E-mail: aptuspharma@rediffmail.com, Website: www.aptus-pharma.com CIN: U24230GJ2010PLC061957, GSTIN: 24AAICA7890D1ZM Earnings Conference Call Invite Aptus Pharma Limited cordially invites you to the Q2 FY27 Earnings Conference Call 26 October 2026, Monday 05:00 PM IST Onwards (For Registered Dial In Access Number Diamond Pass Registration Participants) 086 3457 2003 Click https://reg.dsnl.in/DSNL/form/AptusPha on link rmaLtd/formperma/EvY9p_TgWjn-wsmu 086 4547 4511 SU3PmuZDD9T91LAACQX7bj1XJQQ (For Non-Registered Dial In Participants Participant PIN (For International Participants) Participants) 1. Dial in through the below access numbers to join the call. 1954595# 2. An operator will verify your details and connect you to the call. Represented by Mr. Tejash Hathi - Managing Director Mr. Ghanshyam Pansuriya - CEO Mr. Kapil Chandarana - CFO Mr. Nirav Pandya - Vice President Domestic +91 98791 62647 info@aptuspharma.com www.aptus-pharma.com